Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix granted inducement equity awards to newly hired SVP Kelley Allison, consisting of options to purchase 85,000 shares and RSUs for 28,000 shares. The option grants have an exercise price of $8.99 per share and vest over four years, while the RSUs vest over three years.
Key figures
- Shares granted rsus
- 28000
- Option exercise price
- 8.99
- Shares granted options
- 85000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.